106 related articles for article (PubMed ID: 26375384)
21. A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid.
Chen CJ; Zhao ZX; Wang JC; Zhao EY; Gao LY; Zhou SF; Liu XY; Lu WL; Zhang Q
Int J Nanomedicine; 2012; 7():3837-49. PubMed ID: 22888238
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid-quercetin conjugate micelles: synthesis, characterization, in vitro and in vivo evaluation.
Pang X; Lu Z; Du H; Yang X; Zhai G
Colloids Surf B Biointerfaces; 2014 Nov; 123():778-86. PubMed ID: 25454664
[TBL] [Abstract][Full Text] [Related]
23. Structure and kinetics of lipid-nucleic acid complexes.
Dan N; Danino D
Adv Colloid Interface Sci; 2014 Mar; 205():230-9. PubMed ID: 24529969
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
[TBL] [Abstract][Full Text] [Related]
25. Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by Layer-by-Layer electrostatic deposition for quercetin delivery.
Jeon S; Yoo CY; Park SN
Colloids Surf B Biointerfaces; 2015 May; 129():7-14. PubMed ID: 25819360
[TBL] [Abstract][Full Text] [Related]
26. Interactions between CD44 protein and hyaluronan: insights from the computational study.
Plazinski W; Knys-Dzieciuch A
Mol Biosyst; 2012 Feb; 8(2):543-7. PubMed ID: 22159602
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein-2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells.
Lin CM; Kao WC; Yeh CA; Chen HJ; Lin SZ; Hsieh HH; Sun WS; Chang CH; Hung HS
Nanotechnology; 2015 Mar; 26(10):105101. PubMed ID: 25693888
[TBL] [Abstract][Full Text] [Related]
28. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
29. The effect of liposome size on the final lipid/DNA ratio of cationic lipoplexes.
Gonçalves E; Debs RJ; Heath TD
Biophys J; 2004 Mar; 86(3):1554-63. PubMed ID: 14990482
[TBL] [Abstract][Full Text] [Related]
30. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C
Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
[TBL] [Abstract][Full Text] [Related]
32. Association between cationic liposomes and low molecular weight hyaluronic acid.
Gasperini AA; Puentes-Martinez XE; Balbino TA; Rigoletto Tde P; Corrêa Gde S; Cassago A; Portugal RV; de La Torre LG; Cavalcanti LP
Langmuir; 2015 Mar; 31(11):3308-17. PubMed ID: 25730494
[TBL] [Abstract][Full Text] [Related]
33. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
Jiang G; Park K; Kim J; Kim KS; Hahn SK
Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
[TBL] [Abstract][Full Text] [Related]
34. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D
Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705
[TBL] [Abstract][Full Text] [Related]
35. Mucopenetrating lipoplexes modified with PEG and hyaluronic acid for CD44-targeted local siRNA delivery to the lungs.
Almeida APB; Damaceno GBR; Carneiro AF; Bohr A; Gonçalves HR; Valadares MC; Nascimento TL; Lima EM
J Biomater Appl; 2019 Nov; 34(5):617-630. PubMed ID: 31357900
[No Abstract] [Full Text] [Related]
36. [Physicochemical properties of lipopeptide-based liposomes and their complexes with siRNA].
Turetskiy EA; Koloskova OO; Nosova AS; Shilovskiy IP; Sebyakin YL; Khaitov MR
Biomed Khim; 2017 Oct; 63(5):472-475. PubMed ID: 29080884
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery.
Yin H; Zhao F; Zhang D; Li J
Int J Pharm; 2015 Apr; 483(1-2):169-79. PubMed ID: 25681725
[TBL] [Abstract][Full Text] [Related]
38. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Eliaz RE; Szoka FC
Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
[TBL] [Abstract][Full Text] [Related]
39. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.
Lee H; Mok H; Lee S; Oh YK; Park TG
J Control Release; 2007 Jun; 119(2):245-52. PubMed ID: 17408798
[TBL] [Abstract][Full Text] [Related]
40. An insight on hyaluronic acid in drug targeting and drug delivery.
Yadav AK; Mishra P; Agrawal GP
J Drug Target; 2008 Feb; 16(2):91-107. PubMed ID: 18274931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
